Mekonos (Series A)
Funding Details
Awarder
Inbox
Date Award
November 9, 2021
Vertical
Synthetic Biology and Personalized Medicine
Funding URL
View Funding Page
Funding Amount
$25,000,000
Company Info
Founders
Anil Narasimha
Market
Healthcare
Location
San Francisco, CA, USA
Coinvestors
Debiopharm, Elementum Ventures, Fiscus Ventures, Novartis Pharma AG, Peak6 Investments, Reimagined Ventures, Sands Capital, TDK Ventures
Company Description

Mekonos is an enabling technology company transforming synthetic biology and personalized medicine. The company's SoC merges innovations in MEMS, microfluidics, and chemistry for controlled and individualized molecular delivery in cells at scale.

Links
Back to HomeBack to Synthetic Biology and Personalized Medicine DealsView Funding Announcement